Personalized Implantable Defibrillators

Affiliations

Editorial

Moied M Al Sakan et al. J Cardiovasc Electrophysiol. 2025 Oct.

. 2025 Oct;36(10):2660-2661.

doi: 10.1111/jce.16679. Epub 2025 Apr 9.

¹ Department of Internal Medicine, Division of Cardiology, American University of Beirut Medical Center, Beirut, Lebanon.

No abstract available

Keywords: cardiac arrhythmias; cardiology; cardiovascular diseases; extravascular; implantable cardioverter defibrillator; subcutaneous.

References

1. M. El Moheb, J. Nicolas, A. M. Khamis, G. Iskandarani, E. A. Akl, and M. Refaat, “Implantable Cardiac Defibrillators for People With Non‐Ischaemic Cardiomyopathy,” Cochrane Database of Systematic Reviews 12, no. 12 (2018): CD012738.
1. S. Briongos‐Figuero, A. Sánchez, M. L. Pérez, et al., “Single‐Brand Dual‐Chamber Discriminators to Prevent Inappropriate Shocks in Patients Implanted With Prophylactic Implantable Cardioverter Defibrillators: A Propensity‐Weighted Comparison of Single‐ and Dual‐Chamber Devices,” Journal of Interventional Cardiac Electrophysiology 54, no. 3 (2019): 267–275.
1. P. N. Peterson, P. D. Varosy, P. A. Heidenreich, et al., “Association of Single‐ vs Dualchamber ICDs With Mortality, Readmissions, and Complications Among Patients Receiving an ICD for Primary Prevention,” Journal of the American Medical Association 309, no. 19 (2013): 2025–2034.
1. F. M. Kusumoto, M. H. Schoenfeld, B. L. Wilkoff, et al., “2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction,” Heart Rhythm 14, no. 12 (2017): 503.
1. G. Thomas, D. Y. Choi, H. Doppalapudi, et al., “Subclinical Atrial Fibrillation Detection With a Floating Atrial Sensing Dipole in Single Lead Implantable Cardioverter Defibrillator Systems: Results of the SENSE Trial,” Journal of Cardiovascular Electrophysiology 30, no. 10 (2019): 1994–2001.